Low-risk prostate cancer well managed with active surveillance

As the year comes to a close, we revisit some of this year’s top content on benign prostatic hyperplasia.

Experts discuss overactive bladder and the impacts on quality of life, distinguishing OAB from BPH, and how a delayed diagnosis can worsen symptoms.

Test your knowledge of these often-overlooked but essential aspects of genetic and genomic testing.

In this episode of Speaking of Urology, former MLB player Dave Winfield shares lessons he’s learned throughout his professional baseball career and his work in philanthropy.

The approval of vibegron is supported by data from the phase 3 COURAGE trial.

"I hope that [attendees] will be exposed to a community where they feel that they're able to freely ask questions, gain accurate information, and feel heard, validated, and connected," says Lauren E. Corona, MD.